Dividend and Cash Flow ETFs on SSE Attract Over RMB 23 Billion in Net Inflows in H1

In the first half of 2026, broad-based ETFs listed on the Shanghai Stock Exchange (SSE) distributed a total of RMB 17 billion in dividends. Dividend and cash flow ETFs together paid out nearly RMB 2 billion, accounting for 93% of all ETF dividends distributed in China's domestic market. From the beginning of the year through the end of June, dividend and cash flow ETFs listed on the SSE attracted more than RMB 23 billion in net capital inflows. Meanwhile, the STAR Market Brand Name Drug ETF recorded RMB 1.8 billion in net inflows during the same period and its asset reaching RMB 3 billion, nearly tripling its initial fundraising size. As of the end of June, the SSE had, since the beginning of 2025, facilitated the listing of 36 Main Board broad-based ETFs, 17 dividend ETFs, 16 free cash flow ETFs, and 2 STAR Market Brand Name Drug ETFs. (Yicai, Huang Siyu)